ADMA Biologics Inc - 48 Year Dividend History | ADMA

Historical dividend payout and yield for ADMA Biologics Inc (ADMA) since 1971. The current TTM dividend payout for ADMA Biologics Inc (ADMA) as of April 18, 2019 is $0.00. The current dividend yield for ADMA Biologics Inc as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.214B $0.017B
ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13